Citations

Showing 10 of 108135 citations.

Quality of Life in Jugular Paraganglioma Following Radiosurgery
Patel, Neil , Link, Michael J. , Tombers, Nicole M. , Pollock, Bruce E. , Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | May 25, 2019 | Volume: 40 | Issue: 6 | Pages: 820-825

10.1097/mao.0000000000002250 | PMID 31135667 Get It

Objective: The treatment paradigm for jugular paraganglioma (JP) has changed considerably over time with the wider adoption of stereotactic radiosurgery (SRS). To the best of the authors’ knowledge, there are no published studies that use validated patient-reported outcome measures to ascertain quality of life (QoL) outcomes following SRS for JP when used in single or combined modality treatment regimens. Study Design: Cross-sectional survey. Setting: Tertiary referral center. Patients: Adult patients with JP treated with primary SRS or SRS following primary surgery between 1990 and 2017. Interventions(S): Surgery and/or Gamma Knife SRS. Main Outcome Measures: Global and treatment-related QoL and differences in QoL based on treatment approach. Results: Sixty-nine surveys were distributed and a total of 26 completed surveys were received (38% response rate). Among respondents, the median age at SRS was 53 years and 16 of the 26 patients (62%) were female. Median follow-up was 97 months. Nineteen patients (73%) were treated with primary SRS or staged SRS following intentional subtotal resection (STR; hereafter referred to as “staged SRS”), while the remainder (n = 7, 27%) were treated with SRS for recurrent JP. Median physical and mental health QoL PROMIS-10 T-scores regardless of treatment strategy were 39.8 and 38.8, respectively, while median SF36 physical and mental component subscores were similar to national averages and non-tumor controls. When comparing general physical and mental health QoL scores, there was no significant difference between patients treated with primary or staged SRS and those treated with SRS for recurrent JP. However, age-adjusted swallowing function among patients treated with primary or staged SRS was better than in those patients treated with SRS for recurrent JP (p = 0.05). Conclusions: Patients treated with primary or staged SRS for JP tend to exhibit better swallowing outcomes than those treated with SRS for recurrent JP. However, the majority of overall and disease-specific quality of life measures were not different between groups. Based on the low incidence of new cranial neuropathy following SRS, it is likely that initial surgical morbidity is the primary contributor to this outcome. Disease-specific overall quality of life measures, akin to those already used for other benign skull base tumors, are necessary to better gauge physical and mental health outcomes following treatment for JP. Though limited by small sample size, this represents the first study to gauge QoL outcomes following treatment for JP.
Application of Kaizen Principles to a Large Cochlear Implant Practice: A Continuous Quality Improvement Initiative at Mayo Clinic
Sladen, Douglas P. , Olund, Amy P., Schmitt, Matthew, Benson, Barbara J., DeJong, Melissa D., Dowling, Brittany P., Carlson, Matthew L. , Benson, Barbara, Schmitt, Matthew, Benson, Barbara

Mayo Clinic

Otology & Neurotology | May 25, 2019 | Volume: 40 | Issue: 6 | Pages: e592-e599

10.1097/mao.0000000000002246 | PMID 31135666 Get It

Objective: To remove barriers and improve access for patients seeking cochlear implantation. Study Design: Prospective quality improvement study at a large tertiary academic care center. Methods: A Kaizen quality improvement model was applied over the course of a year. Four weeklong meetings were used to identify areas for improvement and remediation. Data were collected at baseline, 90-days, and 1-year postcompletion of the project. Outcome measures included lead times, defined as the wait time between first contact with the clinic and the first appointment, and the wait time between surgery and activation, and cycle times defined as the total test time needed to determine cochlear implant candidacy, and total time needed to complete initial activation. The total inventory kept as clinic stock was also calculated Results: Kaizen team members collected data for each outcome measure. After the Kaizen principles were applied, the following outcomes were observed: median lead times between first contact with the clinic to candidacy testing, candidacy testing to surgery, and surgery to activation of the implant remained stable from baseline to 1-year follow-up. Median cycle time for candidacy testing decreased from 7.3 hours at baseline to 3.0 hours at 1-year follow-up. Cycle times for initial activation of the device did not change over time. The total inventory of clinic stock was reduced by 31%. Conclusions: Though outcomes for lead and cycle times varied, implementation of Kaizen principles was found to be an effective method for completing this quality improvement project at a large cochlear implant program overall. Level of Evidence: 3a
Acute pancreatitis in end-stage renal disease patients in the USA: a nationwide, propensity score-matched analysis
Cheungpasitporn, Wisit , Ungprasert, Patompong , Wijarnpreecha, Karn , Raimondo, Massimo , Cheungpasitporn, Wisit , Wijarnpreecha, Karn , Thongprayoon, Charat , Kröner, Paul T.

Mayo Clinic

European Journal of Gastroenterology & Hepatology | May 25, 2019 | Volume: 31 | Issue: 8 | Pages: 968-972

10.1097/meg.0000000000001449 | PMID 31136319 Get It

Background Limited data exist regarding the effects of end-stage renal disease (ESRD) on acute pancreatitis (AP). This study aimed to evaluate the association between ESRD and outcomes and resource utilization of AP. Materials and methods The 2014 National Inpatient Sample database was used to identify all hospitalized patients with a principal diagnosis of AP. Propensity score matching was performed to create a matched cohort of ESRD and non-ESRD patients. The in-hospital mortality, morbidity, resource utilization and expenditures of AP in ESRD patients were compared to non-ESRD patients. Multivariate analysis was performed for further adjustment for potential confounders. Results Of 382 595 AP patients, 7380 ESRD patients and 8050 non-ESRD patients were created after propensity score matching. ESRD patients had more tendency to have hypercalcemia-related or AP-related to other/unspecified causes, whereas non-ESRD patients had more tendency to have alcohol-related, gallstone-related, and hypertriglyceridemia-related AP. In multivariate analysis, ESRD was associated with increased in-hospital mortality, increased length of hospital stay, and increased hospitalization costs and charges. No differences were observed in inpatient morbidity, imaging study use, and procedures performed during hospitalization. Conclusion In this large nationwide study using inpatient USA database, we demonstrate higher AP-related mortality, and resource utilization among ESRD patients when compared with non-ESRD patients.
Unusual Imaging Findings Associated with Germ Cell Tumors
Menias, Christine O. , Katabathina, Venkata S. , Craig, Jeffrey W. , Hammer, Mark M. , Magudia, Kirti, Bhalla, Sanjeev , Hammer, Mark M , Magudia, Kirti A.

Mayo Clinic

RadioGraphics | May 24, 2019 | Volume: 39 | Issue: 4 | Pages: 1019-1035

10.1148/rg.2019180050 | PMID 31125295 Get It

The Proliferation of Reports on Clinical Scoring Systems
Challener, Douglas W. , AbuSaleh, Omar, Abu-Saleh, Omar, Challener, Douglas , Prokop, Larry J.

Mayo Clinic

JAMA | May 24, 2019 | Volume: 321 | Issue: 24 | Pages: 2405

10.1001/jama.2019.5284 | PMID 31125046 Get It

Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations
Camilleri, Michael , Lyle, Barbara J. , Madsen, Karen , Sonnenburg, Justin L. , Verbeke, Kristin , Wu, Gary D.

Mayo Clinic

American Journal of Physiology-Gastrointestinal and Liver Physiology | May 24, 2019 | Volume: 317 | Issue: 1 | Pages: G17-G39

10.1152/ajpgi.00063.2019 | PMID 31125257 Get It

A reduction in intestinal barrier function is currently believed to play an important role in pathogenesis of many diseases, as it facilitates passage of injurious factors such as lipopolysaccharide, peptidoglycan, whole bacteria, and other toxins to traverse the barrier to damage the intestine or enter the portal circulation. Currently available evidence in animal models and in vitro systems has shown that certain dietary interventions can be used to reinforce the intestinal barrier to prevent the development of disease. The relevance of these studies to human health is unknown. Herein, we define the components of the intestinal barrier, review available modalities to assess its structure and function in humans, and review the available evidence in model systems or perturbations in humans that diet can be used to fortify intestinal barrier function. Acknowledging the technical challenges and the present gaps in knowledge, we provide a conceptual framework by which evidence could be developed to support the notion that diet can reinforce human intestinal barrier function to restore normal function and potentially reduce the risk for disease. Such evidence would provide information on the development of healthier diets and serve to provide a framework by which federal agencies such as the US Food and Drug Administration can evaluate evidence linking diet with normal human structure/function claims focused on reducing risk of disease in the general public.
Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child
Reddy, Kavita S., Rai, Ashutosh , Madugundu, Anil K. , Solanki, Hitendra S. , Bhansali, Anil , Radotra, Bishan, Kumar, Narendra , Iacovazzo, Donato , Gupta, Prakamya , Raja, Remya , Pandey, Akhilesh , Devgun, Jagtar Singh, Korbonits, Márta , Pandey, Akhilesh , Pandey, Akhilesh , Dutta, Pinaki R , Reddy, Kavita S, Collier, David , Gowda, Harsha

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | May 24, 2019 | Volume: 104 | Issue: 8 | Pages: 3539-3544

10.1210/jc.2019-00432 | PMID 31125088 Get It

AbstractContextInactivating germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene are linked to pituitary adenoma predisposition. Here, we present the youngest known patient with AIP-related pituitary adenoma.Case DescriptionThe patient presented at the age of 4 years with pituitary apoplexy and left ptosis with severe visual loss following a 1-year history of abdominal pain, headaches, and rapid growth. His IGF-1 level was 5× the upper limit of normal, and his random GH level was 1200 ng/mL. MRI showed a 43 × 24 × 35‒mm adenoma with suprasellar extension invading the left cavernous sinus (Knosp grade 4). After transsphenoidal surgery, histology showed a grade 2A sparsely granulated somatotropinoma with negative O6-methylguanine-DNA methyltransferase and positive vascular endothelial growth factor staining. Genetic testing identified a heterozygous germline nonsense AIP mutation (p.Arg81Ter). Exome sequencing of the tumor revealed that it had lost the entire maternal chromosome-11, rendering it hemizygous for chromosome-11 and therefore lacking functional copies of AIP in the tumor. He was started on octreotide, but because the tumor rapidly regrew and IGF-1 levels were unchanged, temozolomide was initiated, and intensity-modulated radiotherapy was administered 5 months after surgery. Two months later, bevacizumab was added, resulting in excellent tumor response. Although these treatments stabilized tumor growth over 4 years, IGF-1 was normalized only after pegvisomant treatment, although access to this medication was intermittent. At 3.5 years of follow-up, gamma knife treatment was administered, and pegvisomant dose increase was indicated.ConclusionMultimodal treatment with surgery, long-acting octreotide, radiotherapy, temozolomide, bevacizumab, and pegvisomant can control genetically driven, aggressive, childhood-onset somatotropinomas.
In Reply to Starr et al
Montori, Víctor M.

Mayo Clinic

Academic Medicine | May 24, 2019 | Volume: 94 | Issue: 6 | Pages: 747-747

10.1097/acm.0000000000002706 | PMID 31136338 Get It

Moving Our Education Priorities From Sickness to Health: The Opportunity for Health Promotion, Disease Prevention, and Population Health to Transform Health Professions Education
Peña, Austin, Sklar, David P.

Mayo Clinic

Academic Medicine | May 24, 2019 | Volume: 94 | Issue: 6 | Pages: 741-743

10.1097/acm.0000000000002699 | PMID 31136333 Get It

Rethinking the Cost of High-Value Care
Starr, Stephanie R. , Agrwal, Neera , Hunderfund, Andrea N. Leep

Mayo Clinic

Academic Medicine | May 24, 2019 | Volume: 94 | Issue: 6 | Pages: 747-747

10.1097/acm.0000000000002683 | PMID 31136337 Get It